Previous 10 | Next 10 |
CLEVELAND , May 2, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the first quarter ended March 31, 2019 . First Quarter 2019 Highlights: Received 7 new orders for MRIdian systems totaling $42.8 million , compared to 3 orders...
CLEVELAND , April 23, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company's MRIdian MRI-guided radiation therapy system will be featured at the Annual Meeting of the European Society for Radiotherapy and Oncology (ESTRO), with a number of presentat...
ViewRay (NASDAQ: VRAY ) has partnered with Minogue Medical Inc. More news on: ViewRay, Inc., Healthcare stocks news, Read more ...
April 18, 2019 Palm Beach, FL –April 18, 2019 – The global cellulite market and its largest segment, the non-invasive treatment sector, are both expected to grow at a healthy rate. A recent industry report on the entire cellulite market (from Transparency Market Research)...
CLEVELAND , April 18, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company has partnered with Minogue Medical Inc., a leading Canadian distributor of surgical devices, operating room disposables, hospital equipment, and simulators for medical education. ...
CLEVELAND , April 17, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) and Device Technologies Australia Pty Ltd (Device Technologies) announced today a partnership in which Device Technologies, the largest independent distributor in Australasia, will market, sell, and support Vi...
CLEVELAND , April 11, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its first quarter 2019 financial results. ViewRay will hold a conference call to discuss results on Thursday, May 2, 2019 at 4:30 p.m. ET / 1:30 p....
ViewRay ( VRAY +0.5% ) is up out the gate this morning on the heels of a just-published retrospective analysis of the outcomes of MRI-guided radiation therapy delivered with its MRIdian system in patients with locally advanced pancreatic cancer. The study appears in this month's edition ...
CLEVELAND , April 11, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today the publication of a retrospective analysis of outcomes for the stereotactic treatment of locally advanced pancreatic cancer using precise, high-dose MRI-guided radiation therapy delivered with ...
Gainers: MKTX +3.8% . WTRE +3.1% . CBLK +3.1% . PRNB +2.1% . VALE +1.7% . More news on: MarketAxess Holdings Inc., Watford Holdings Ltd., Carbon Black, Inc., Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR Newswire DENVER , July 21, 2023 /PRNewswire/ -- ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17 , i...